Beijing Sun-Novo Pharmaceutical Research Co Ltd
SSE:688621
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beijing Sun-Novo Pharmaceutical Research Co Ltd
SSE:688621
|
CN |
|
G
|
GSI Technology Inc
XBER:ZS6
|
US |
|
R
|
Ral Yatirim Holding AS
IST:RALYH.E
|
TR |
|
Eagle Pharmaceuticals Inc
NASDAQ:EGRX
|
US |
|
M
|
Metro Bank Holdings PLC
OTC:MTRBF
|
UK |
|
M
|
Mpact Ltd
JSE:MPT
|
ZA |
|
P
|
Phong Phu Pharmaceutical JSC
VN:PPP
|
VN |
|
Herige SA
PAR:ALHRG
|
FR |
|
Haivision Systems Inc
TSX:HAI
|
CA |
|
Inter & Co Inc
NASDAQ:INTR
|
BR |
|
E
|
Eviso SpA
MIL:EVS
|
IT |
|
B
|
Bank of Gansu Co Ltd
HKEX:2139
|
CN |
|
WEHA Transportasi Indonesia Tbk PT
IDX:WEHA
|
ID |
|
Banco Products (India) Ltd
NSE:BANCOINDIA
|
IN |
|
A
|
Aboitiz Equity Ventures Inc
XPHS:AEV
|
PH |
|
Adamant DRI Processing and Minerals Group
OTC:ADMG
|
CN |
|
Cybertech Systems and Software Ltd
NSE:CYBERTECH
|
IN |
|
Trent Ltd
NSE:TRENT
|
IN |
Beijing Sun-Novo Pharmaceutical Research Co Ltd
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. engages in the research and development of pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 873 full-time employees. The company went IPO on 2021-06-21. The firm's main businesses include comprehensive research and development services in generic drug development, consistency evaluation and innovative drug development. Its services mainly include pharmaceutical research, clinical trials and biological analysis. Pharmaceutical research services include raw materials and preparation process research, quality standards and stability research, etc. Clinical trial services include phase I-IV clinical trial research, Bioequivalency (BE) test research. Biological analysis services include the use of mass spectrometry analysis platform, immunoassay platform, cell analysis platform, molecular biology analysis platform for method development, method validation, biological sample detection research, etc. The firm mainly conducts its businesses in the domestic market.
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. engages in the research and development of pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 873 full-time employees. The company went IPO on 2021-06-21. The firm's main businesses include comprehensive research and development services in generic drug development, consistency evaluation and innovative drug development. Its services mainly include pharmaceutical research, clinical trials and biological analysis. Pharmaceutical research services include raw materials and preparation process research, quality standards and stability research, etc. Clinical trial services include phase I-IV clinical trial research, Bioequivalency (BE) test research. Biological analysis services include the use of mass spectrometry analysis platform, immunoassay platform, cell analysis platform, molecular biology analysis platform for method development, method validation, biological sample detection research, etc. The firm mainly conducts its businesses in the domestic market.
